These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
165 related articles for article (PubMed ID: 6895386)
1. Microsomal nitroreductase activity of rabbit kidney and bladder: implications in 5-nitrofuran-induced toxicity. Zenser TV; Mattammal MB; Palmier MO; Davis BB J Pharmacol Exp Ther; 1981 Dec; 219(3):735-40. PubMed ID: 6895386 [TBL] [Abstract][Full Text] [Related]
2. Comparative effects of prostaglandin H synthase-catalyzed binding of two 5-nitrofuran urinary bladder carcinogens. Zenser TV; Palmier MO; Mattammal MB; Bolla RI; Davis BB J Pharmacol Exp Ther; 1983 Oct; 227(1):139-43. PubMed ID: 6413679 [TBL] [Abstract][Full Text] [Related]
3. Aspirin inhibition of N-[4-(5-nitro-2-furyl)-2-thiazolyl]formamide-induced lesions of the urinary bladder correlated with inhibition of metabolism by bladder prostaglandin endoperoxide synthetase. Cohen SM; Zenser TV; Murasaki G; Fukushima S; Mattammal MB; Rapp NS; Davis BB Cancer Res; 1981 Sep; 41(9 Pt 1):3355-9. PubMed ID: 6790163 [TBL] [Abstract][Full Text] [Related]
4. Renal reduced nicotinamide adenine dinucleotide phosphate:cytochrome c reductase-mediated metabolism of the carcinogen N-[4-(5-nitro-2-furyl)-2-thiazolyl]acetamide. Mattammal MB; Zenser TV; Palmier MO; Davis BB Cancer Res; 1985 Jan; 45(1):149-56. PubMed ID: 3917370 [TBL] [Abstract][Full Text] [Related]
5. Metabolism of N-[4-(5-nitro-2-furyl)-2-thiazolyl]formamide by prostaglandin endoperoxide synthetase. Zenser TV; Mattammal MB; Davis BB Cancer Res; 1980 Jan; 40(1):114-8. PubMed ID: 6765914 [TBL] [Abstract][Full Text] [Related]
6. Prostaglandin hydroperoxidase-mediated 2-amino-4-(5-nitro-2-furyl) [14C]thiazole metabolism and nucleic acid binding. Mattammal MB; Zenser TV; Davis BB Cancer Res; 1981 Dec; 41(12 Pt 1):4961-6. PubMed ID: 6796263 [TBL] [Abstract][Full Text] [Related]
7. Metabolic activation of carcinogenic aromatic amines by dog bladder and kidney prostaglandin H synthase. Wise RW; Zenser TV; Kadlubar FF; Davis BB Cancer Res; 1984 May; 44(5):1893-7. PubMed ID: 6424934 [TBL] [Abstract][Full Text] [Related]
8. Biotransformation of the bladder carcinogen N-[4-(5-nitro-2-furyl)-2-thiazolyl]formamide in mice. Swaminathan S; Bryan GT Cancer Res; 1984 Jun; 44(6):2331-8. PubMed ID: 6722771 [TBL] [Abstract][Full Text] [Related]
9. Metabolism and disposition of bladder carcinogens in rat and guinea pig: possible mechanism of guinea pig resistance to bladder cancer. Dawley RM; Zenser TV; Mattammal MB; Lakshmi VM; Hsu FF; Davis BB Cancer Res; 1991 Jan; 51(2):514-20. PubMed ID: 1898713 [TBL] [Abstract][Full Text] [Related]
10. Enhancing effect of allopurinol on the induction of bladder cancer in rats by n-[4-(5-nitro-2-furyl)-2-thiazolyl]formamide. Wang CY; Hayashida S; Pamukcu AM; Bryan GT Cancer Res; 1976 May; 36(5):1551-5. PubMed ID: 1268818 [TBL] [Abstract][Full Text] [Related]
11. Enhanced macromolecular binding of N-[4-(5-nitro-2-furyl)-2-thiazolyl]- formamide in germfree versus conventional rats. Morton KC; Wang CY Cancer Res; 1983 Aug; 43(8):3628-32. PubMed ID: 6190554 [TBL] [Abstract][Full Text] [Related]
12. Transport of the renal carcinogen 3-hydroxymethyl-1-([3-(5-nitro-2-furyl)allydidene]amino) hydantoin by renal cortex and cooxidative metabolism by prostaglandin endoperoxide synthetase. Zenser TV; Balasubramanian TM; Mattammal MB; Davis BB Cancer Res; 1981 Jun; 41(6):2032-7. PubMed ID: 6786731 [TBL] [Abstract][Full Text] [Related]
13. Effect of aspirin on urinary bladder carcinogenesis initiated with N-[4-(5-nitro-2-furyl)-2-thiazolyl]formamide in rats. Cohen SM; Hasegawa R; Sakata T; Johansson SL Cancer Res; 1989 Jan; 49(2):372-7. PubMed ID: 2491954 [TBL] [Abstract][Full Text] [Related]
14. Anaerobic metabolism and nuclear binding of the carcinogen 2-amino-4-(5-nitro-2-furyl)thiazole (ANFT). Mattammal MB; Zenser TV; Davis BB Carcinogenesis; 1982; 3(11):1339-44. PubMed ID: 6817938 [TBL] [Abstract][Full Text] [Related]
15. Enhancement by phenothiazine and 2,5-di-O-acetyl-D-glucosaccharo-(1,4)(6,3)-dilactone of bladder carcinogenicity of N-[4-(5-nitro-2-furyl)-2-thiazolyl]-formamide in rats. Wang CY; Hayashida S Cancer Lett; 1984 Aug; 24(1):37-43. PubMed ID: 6548659 [TBL] [Abstract][Full Text] [Related]
16. Enhancement of N-[4-(5-nitro-2-furyl)-2-thiazolyl]formamide-induced carcinogenesis by urinary tract infection in rats. Johansson SL; Anderström C; von Schultz L; Larsson P Cancer Res; 1987 Jan; 47(2):559-62. PubMed ID: 3539325 [TBL] [Abstract][Full Text] [Related]
17. Nitroreductase-mediated metabolic activation of 2-amino-4-(5-nitro-2-furyl)thiazole and binding to nucleic acids and proteins. Swaminathan S; Lower GM; Bryan GT Cancer Res; 1982 Nov; 42(11):4479-84. PubMed ID: 6751523 [No Abstract] [Full Text] [Related]
18. Role of renal metabolism and excretion in 5-nitrofuran-induced uroepithelial cancer in the rat. Spry LA; Zenser TV; Cohen SM; Davis BB J Clin Invest; 1985 Sep; 76(3):1025-31. PubMed ID: 4044826 [TBL] [Abstract][Full Text] [Related]
19. Effect of peroxidase inhibitors on an in vivo metabolite of the urinary bladder carcinogen N-[4-(5-nitro-2-furyl)-2-thiazolyl]formamide in rats. Rice JR; Spry LA; Zenser TV; Davis BB Cancer Res; 1988 Jan; 48(2):304-9. PubMed ID: 3121171 [TBL] [Abstract][Full Text] [Related]
20. 'Revised' mass spectral identification of 2-amino-4-(5-nitro-2-furyl)thiazole metabolites. Mattammal MB; Lakshmi VM; Zenser TV; Davis BB; White E Biomed Environ Mass Spectrom; 1988 May; 15(9):495-9. PubMed ID: 3382804 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]